Contrarily, FGF21 enhances cardiac function and reduces Ang II induced cardiac hypertrophy through in silent information regulator 1 (SIRT1)/adenosine monophosphate-activated protein kinase (AMPK) pathway (Li S et al., 2019). Here, SIRT1 is linked to cardiac hypertrophy.